Cell : The Lancet - Translational Medicine

Speaker

David B. CLIFFORD, Washington University School of Medicine, St. Louis, USA

David B. CLIFFORDDr. Clifford is the Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology at Washington University in St. Louis. He has broad research interests in neuropharmacology and has worked in epilepsy, movement disorders, multiple sclerosis, Alzheimer’s disease and HIV associated neurological conditions. Since 1993, he led the Neurologic AIDS Research Consortium (NARC) , an NIH funded national research group developing improved therapy for neuroAIDS complications.   He is the Principal Investigator of the AIDS Clinical Trials Unit at Washington University, as well as being active investigator in the CHARTER study. 

He has participated in neuroAIDS research in Ethiopia, Uganda, Bangkok, Senegal, The Gambia and Guinea Bissau.  He also has studied complications of immunodeficiency. Progressive multifocal leukoencephalopathy has become a major focus of his work as it has gained importance in targeted therapies for inflammatory diseases including multiple sclerosis. He also has worked on degenerative diseases, including the potential interactions of HIV and aging, and Alzheimer’s disease.  He is an investigator of the Washington University Alzheimer Disease Research Center, and is the Medical Monitor for the Dominantly Inherited Alzheimer Network (DIAN) Treatment Trial.  He also leads the NeuroNEXT unit at Washington University, an NIH funded Phase 2 biomarkers drug development network. 

« Go Back

Organized by

Elsevier
Journal - The Lancet
Journal - Cell
Elsevier

Partners

Timothy Ray Brown
World AIDS Institute